Evofem Biosciences (EVFM) Accounts Payables (2014 - 2026)
Evofem Biosciences (EVFM) recorded Accounts Payables of $12.15 million in Q2 2026, down 1.1% from $12.29 million a year earlier but up 1.2% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Accounts Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, Evofem Biosciences reported Accounts Payables of $13.15 million, up 592.3% from FY2024.
- Annual Accounts Payables has a five-year compound annual growth rate of 4.3% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $1.9 million in FY2024 (-88.8%), $17.02 million in FY2023 (+13.6%), $14.98 million in FY2022 (+45.3%) and $10.32 million in FY2021 (-3.1%).
- Quarterly Accounts Payables has ranged from $1.9 million in Q4 2024 to $18.8 million in Q1 2023 over the past five years.
- On a year-over-year basis, Accounts Payables rose in three of the last eight quarters, with growth averaging 53.5%.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 592.3% in Q4 2025, against a decline of 88.8% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $12 million (Q1 2026), $13.15 million (Q4 2025) and $11.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | 12.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.15 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 13.15 Mn |
| Sep 30, 2025 | 11.62 Mn |
| Jun 30, 2025 | 12.29 Mn |
| Mar 31, 2025 | 11.22 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 16.86 Mn |
| Jun 30, 2024 | 16.03 Mn |
| Mar 31, 2024 | 16.29 Mn |
| Dec 31, 2023 | 17.02 Mn |
| Sep 30, 2023 | 16.20 Mn |
| Jun 30, 2023 | 17.15 Mn |
| Mar 31, 2023 | 18.80 Mn |
| Dec 31, 2022 | 14.98 Mn |
| Sep 30, 2022 | 14.54 Mn |
| Jun 30, 2022 | 15.39 Mn |
| Mar 31, 2022 | 14.04 Mn |
| Dec 31, 2021 | 10.32 Mn |
| Sep 30, 2021 | 6.79 Mn |
API Access
Evofem Biosciences Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();